Why insider trading matters?

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

- Peter Lynch
Myovant Sciences Ltd. (MYOV)
Sector: Healthcare; Industry: Biotechnology

Myovant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for women's health and endocrine diseases. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain, and advanced prostate cancer. The company was founded in 2016 and is based in London, the United Kingdom.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2023-01-18 Lang Matthew General Counsel & Corp. Secy. Sell 1,272 $26.89 $34,204 No
2023-01-18 Merendino Lauren Chief Commercial Officer Sell 2,008 $26.89 $53,995 No
2023-01-18 Arjona Ferreira Juan Camilo Chief Medical Officer Sell 1,109 $26.89 $29,821 No
2023-01-04 Arjona Ferreira Juan Camilo Chief Medical Officer Sell 2,251 $26.90 $60,552 No
2023-01-04 Lang Matthew General Counsel & Corp. Secy. Sell 2,779 $26.90 $74,755 No
2022-12-16 Mehra Uneek Principal Financial Officer Sell 2,241 $26.75 $59,947 No
2022-10-18 Merendino Lauren Chief Commercial Officer Sell 1,703 $25.20 $42,916 No
2022-10-18 Lang Matthew General Counsel & Corp. Secy. Sell 1,933 $25.20 $48,712 No
2022-10-18 Arjona Ferreira Juan Camilo Chief Medical Officer Sell 1,604 $25.20 $40,421 No
2022-10-04 Arjona Ferreira Juan Camilo Chief Medical Officer Sell 2,738 $24.40 $66,807 No
2022-09-16 Mehra Uneek Principal Financial Officer Sell 9,243 $18.86 $174,323 No
2022-08-15 Lang Matthew General Counsel & Corp. Secy. Sell 31,214 $18.23 $569,031 No
2022-07-18 Lang Matthew General Counsel & Corp. Secy. Sell 1,935 $12.87 $24,903 No
2022-07-18 Merendino Lauren Chief Commercial Officer Sell 1,704 $12.87 $21,930 No
2022-07-18 Marek David C Principal Executive Officer Sell 11,164 $12.87 $143,681 No
2022-07-06 Lang Matthew General Counsel & Corp. Secy. Sell 3,702 $13.40 $49,607 No
2022-04-19 Lang Matthew General Counsel & Corp. Secy. Sell 8,002 $10.45 $83,621 No
2022-04-19 Arjona Ferreira Juan Camilo Chief Medical Officer Sell 4,632 $10.45 $48,404 No
2022-04-19 Merendino Lauren Chief Commercial Officer Sell 7,049 $10.45 $73,662 No
2022-04-19 Marek David C Principal Executive Officer Sell 24,594 $10.45 $257,007 No
2022-04-05 Lang Matthew General Counsel & Corp. Secy. Sell 2,436 $13.78 $33,568 No
2022-03-01 Arjona Ferreira Juan Camilo Chief Medical Officer Sell 1,362 $13.35 $18,183 No
2022-01-19 Marek David C Principal Executive Officer Sell 19,882 $14.68 $291,868 No
2022-01-04 Lang Matthew General Counsel & Corp. Secy. Sell 4,475 $16.27 $72,808 No
2021-11-29 Arjona Ferreira Juan Camilo Chief Medical Officer Sell 1,978 $19.30 $38,175 No
2021-11-04 Arjona Ferreira Juan Camilo Chief Medical Officer Sell 3,800 $24.02 $91,262 Yes
2021-10-05 Arjona Ferreira Juan Camilo Chief Medical Officer Sell 2,738 $21.62 $59,196 No
2021-10-05 Lang Matthew General Counsel & Corp. Secy. Sell 6,671 $21.62 $144,227 No
2021-09-27 Arjona Ferreira Juan Camilo Chief Medical Officer Sell 7,000 $24.32 $170,240 Yes
2021-09-27 Sumitomo Chemical Co., Ltd. 10%-Owner Buy 84,000 $23.87 $2,004,937 No

Insider Smart

VBI Vaccines Inc (VBIV) - Since 10%-owner Perceptive Advisor LCC increased their holding in April, the stock have double the price. Impressive!

Insider Smart

CARNIVAL CORP (CCL) - Cruislines $CCL $NCLH $RCL took a huge beat due to the pandemic, concerns of bankruptcy were raised. Among the three dominating companies in the industry, $CCL is the first one bought by insiders, such a bold move would definitely boost investor confidence.